Ruffolo RR - Search Results

1

Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke.

Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL, Finklestein SP, Pangalos MN, Poole M, Stiles GL, Ruffolo RR, Walsh FL. Feuerstein GZ, et al. Among authors: ruffolo rr. J Cereb Blood Flow Metab. 2008 Jan;28(1):217-9. doi: 10.1038/sj.jcbfm.9600516. Epub 2007 Jun 20. J Cereb Blood Flow Metab. 2008. PMID: 17579658 Review.

2

Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective.

Feuerstein GZ, Ruffolo RR. Feuerstein GZ, et al. Among authors: ruffolo rr. Expert Opin Investig Drugs. 2007 Sep;16(9):1315-26. doi: 10.1517/13543784.16.9.1315. Expert Opin Investig Drugs. 2007. PMID: 17714019 Review.

3

Carvedilol case history: the discovery and development of the first β-blocker for the treatment of congestive heart failure.

Ruffolo RR, Feuerstein GZ. Ruffolo RR, et al. Expert Opin Drug Discov. 2006 Jun;1(1):85-9. doi: 10.1517/17460441.1.1.85. Expert Opin Drug Discov. 2006. PMID: 23506034

4

Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.

Ruffolo RR Jr, Feuerstein GZ. Ruffolo RR Jr, et al. Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:247-56. doi: 10.1023/a:1007735729121. Cardiovasc Drugs Ther. 1997. PMID: 9211017 Review.

5

Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.

Feuerstein G, Ruffolo RR Jr. Feuerstein G, et al. Among authors: ruffolo rr jr. Adv Pharmacol. 1998;42:611-5. doi: 10.1016/s1054-3589(08)60825-x. Adv Pharmacol. 1998. PMID: 9327976 No abstract available.

6

Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure.

Ruffolo RR Jr, Feuerstein GZ. Ruffolo RR Jr, et al. J Cardiovasc Pharmacol. 1998;32 Suppl 1:S22-30. doi: 10.1097/00005344-199800003-00005. J Cardiovasc Pharmacol. 1998. PMID: 9731692 Review.

7

Congestive heart failure and genomic medicine: a look into the 21st century.

Feuerstein GZ, Ruffolo RR Jr. Feuerstein GZ, et al. Among authors: ruffolo rr jr. Cardiovasc Drugs Ther. 1997 Dec;11(6):713-7. doi: 10.1023/a:1007716021473. Cardiovasc Drugs Ther. 1997. PMID: 9512865 Review.

8

Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.

Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR Jr. Feuerstein GZ, et al. Among authors: ruffolo rr jr. J Hypertens Suppl. 1993 Jun;11(4):S41-8. J Hypertens Suppl. 1993. PMID: 8104241

9

Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.

Feuerstein GZ, Ruffolo RR Jr. Feuerstein GZ, et al. Among authors: ruffolo rr jr. Eur Heart J. 1996 Apr;17 Suppl B:24-9. doi: 10.1093/eurheartj/17.suppl_b.24. Eur Heart J. 1996. PMID: 8733068 Review.

10

Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.

Yue TL, Wang X, Gu JL, Ruffolo RR Jr, Feuerstein GZ. Yue TL, et al. Among authors: ruffolo rr jr. J Pharmacol Exp Ther. 1995 Jun;273(3):1442-9. J Pharmacol Exp Ther. 1995. PMID: 7791119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page